Featured Announcements | China Aluminum International signs new contracts of 11 billion yuan in the first quarter, an increase of over 50% year-on-year
Featured Announcements 1. $Ascletis Pharma-B(01672.HK)$ : 3CLpro inhibitor ASC11 is expected to become an effective drug for the treatment of new coronary pneumonia Ascletis Pharma-B announced that its oral small molecule drug candidate ASC11 (3CLpro inhibitor) is expected to become an effective drug for the treatment of new coronary pneumonia. It is reported that ASC11 […]